| Description | Plamotamab (XmAb-13676), a human bispecific antibody (bsAb) targeting CD3 and CD20, recruits cytotoxic T cells to eliminate CD20-expressing tumor cells. It demonstrates mild hematologic reaction (MR) and effectively induces tumor regression in vivo [1] [2]. |
| molecular weight | N/A |
| CAS | 2138442-31-4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |